-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on OKYO Pharma Ltd. (OKYO)
-
-
-
-
-
-
-
OKYO Pharma plans 100-patient trial for neuropathic corneal pain drug
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on OKYO Pharma Ltd. (OKYO)
-
-
-
-
-
-
-
MUSQ Global Music Industry ETF and OKYO Pharma Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on OKYO Pharma Ltd. (OKYO)
-
-
-
-
-
-
-
OKYO Pharma (OKYO) to Initiate Neuropathic Corneal Pain Trial for OK-101
-
-
-
430,171 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

